In the current study, we hypothesized that in BRCA1 and BRCA2-negative families with elevated BC risk, the analysis of a large array of genes previously associated to (hereditary) cancer syndromes or cancer in general, could likely lead to the identification of additional candidate BC predisposing genes/variants. This evidence concerns the gene BRCA2 and breast cancer.